SEXUAL ASSESSMENT IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS: ARE THEY INTERESTED ON SEXOLOGY CONSULTATION?

被引：0
|
作者：
Angles-Acedo, S. [1 ]
Ribera-Torres, L. [1 ]
Mension, E. [1 ]
Gomez Carballo, S. [1 ]
Tortajada, M. [1 ]
Matas, I [1 ]
Alonso, I [1 ]
Castelo-Branco, C. [1 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
来源：
JOURNAL OF SEXUAL MEDICINE | 2022年 / 19卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
115
引用
收藏
页码：S170 / S171
页数：2
相关论文
共 50 条
  • [41] Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
    Chim, Kannie
    Xie, Sharon X.
    Stricker, Carrie T.
    Li, Qing S.
    Gross, Robert
    Farrar, John T.
    DeMichele, Angela
    Mao, Jun J.
    BMC CANCER, 2013, 13
  • [42] Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors
    Brier, Moriah J.
    Chambless, Dianne L.
    Chen, Jinbo
    Mao, Jun J.
    EUROPEAN JOURNAL OF CANCER, 2018, 91 : 145 - 152
  • [43] Perceived Barriers to Treatment Predict Adherence to Aromatase Inhibitors Among Breast Cancer Survivors
    Brier, Moriah J.
    Chambless, Dianne L.
    Gross, Robert
    Chen, Jinbo
    Mao, Jun J.
    CANCER, 2017, 123 (01) : 169 - 176
  • [44] Vaginal microbiomes of breast cancer survivors treated with aromatase inhibitors with and without vulvovaginal symptoms
    Prasanchit, Pimpun
    Pongchaikul, Pisut
    Lertsittichai, Panuwat
    Tantitham, Chananya
    Manonai, Jittima
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [45] ASSESSMENT OF OSTEOPOROSIS RISK IN PATIENTS INTIATING AROMATASE INHIBITORS FOR BREAST CANCER
    Dolan, L.
    Vandenbosch, P.
    Kendall, J.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S302 - S303
  • [46] Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors or Tamoxifen
    Lintermans, A.
    Dieudonne, A. S.
    Vanderhaegen, J.
    Henry, N. L.
    Wildiers, H.
    Paridaens, R.
    Christiaens, M. R.
    Smeets, A.
    Leunen, K.
    Neven, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S159 - S160
  • [47] Prospective assessment of loss of grip strength by baseline BMI in breast cancer patients receiving adjuvant aromatase inhibitors or tamoxifen
    Lintermans, A.
    Van Asten, K.
    Wildiers, H.
    Paridaens, R.
    Weltens, C.
    Van Limbergen, E.
    Smeets, A.
    Leunen, K.
    Christiaens, M. R.
    Neven, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S99 - S99
  • [48] BREAST CANCER Aromatase inhibitors-bone health assessment is crucial
    Hadji, Peyman
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (05) : 254 - 255
  • [49] Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More?
    Dhesy-Thind, Sukhbinder K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) : 1408 - 1410
  • [50] Aromatase inhibitors and male breast cancer
    E. Arriola
    E. Hui
    M. Dowsett
    I. E. Smith
    Clinical and Translational Oncology, 2007, 9 : 192 - 194
12345